186 related articles for article (PubMed ID: 14656482)
1. Inhibition of steroidogenesis in Leydig cells by Müllerian-inhibiting substance.
Fynn-Thompson E; Cheng H; Teixeira J
Mol Cell Endocrinol; 2003 Dec; 211(1-2):99-104. PubMed ID: 14656482
[TBL] [Abstract][Full Text] [Related]
2. Steroidogenic activities in MA-10 Leydig cells are differentially altered by cAMP and Müllerian inhibiting substance.
Trbovich AM; Martinelle N; O'Neill FH; Pearson EJ; Donahoe PK; Sluss PM; Teixeira J
J Steroid Biochem Mol Biol; 2004 Oct; 92(3):199-208. PubMed ID: 15555913
[TBL] [Abstract][Full Text] [Related]
3. Müllerian inhibiting substance blocks the protein kinase A-induced expression of cytochrome p450 17alpha-hydroxylase/C(17-20) lyase mRNA in a mouse Leydig cell line independent of cAMP responsive element binding protein phosphorylation.
Laurich VM; Trbovich AM; O'Neill FH; Houk CP; Sluss PM; Payne AH; Donahoe PK; Teixeira J
Endocrinology; 2002 Sep; 143(9):3351-60. PubMed ID: 12193547
[TBL] [Abstract][Full Text] [Related]
4. Müllerian-inhibiting substance regulates androgen synthesis at the transcriptional level.
Teixeira J; Fynn-Thompson E; Payne AH; Donahoe PK
Endocrinology; 1999 Oct; 140(10):4732-8. PubMed ID: 10499532
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of the rat Müllerian inhibiting substance type II receptor in rodent Leydig cells.
Teixeira J; Kehas DJ; Antun R; Donahoe PK
Proc Natl Acad Sci U S A; 1999 Nov; 96(24):13831-8. PubMed ID: 10570158
[TBL] [Abstract][Full Text] [Related]
6. Müllerian Inhibiting Substance lowers testosterone in luteinizing hormone-stimulated rodents.
Trbovich AM; Sluss PM; Laurich VM; O'Neill FH; MacLaughlin DT; Donahoe PK; Teixeira J
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3393-7. PubMed ID: 11248089
[TBL] [Abstract][Full Text] [Related]
7. Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression.
Clarke TR; Hoshiya Y; Yi SE; Liu X; Lyons KM; Donahoe PK
Mol Endocrinol; 2001 Jun; 15(6):946-59. PubMed ID: 11376113
[TBL] [Abstract][Full Text] [Related]
8. Mullerian inhibiting substance recruits ALK3 to regulate Leydig cell differentiation.
Wu X; Zhang N; Lee MM
Endocrinology; 2012 Oct; 153(10):4929-37. PubMed ID: 22872577
[TBL] [Abstract][Full Text] [Related]
9. The serine/threonine transmembrane receptor ALK2 mediates Müllerian inhibiting substance signaling.
Visser JA; Olaso R; Verhoef-Post M; Kramer P; Themmen AP; Ingraham HA
Mol Endocrinol; 2001 Jun; 15(6):936-45. PubMed ID: 11376112
[TBL] [Abstract][Full Text] [Related]
10. Synergistic cooperation between the beta-catenin signaling pathway and steroidogenic factor 1 in the activation of the Mullerian inhibiting substance type II receptor.
Hossain A; Saunders GF
J Biol Chem; 2003 Jul; 278(29):26511-6. PubMed ID: 12724325
[TBL] [Abstract][Full Text] [Related]
11. Enhanced purification and production of Müllerian inhibiting substance for therapeutic applications.
Donahoe PK; Clarke T; Teixeira J; Maheswaran S; MacLaughlin DT
Mol Cell Endocrinol; 2003 Dec; 211(1-2):37-42. PubMed ID: 14656474
[TBL] [Abstract][Full Text] [Related]
12. Feedback inhibition of steroidogenic acute regulatory protein expression in vitro and in vivo by androgens.
Houk CP; Pearson EJ; Martinelle N; Donahoe PK; Teixeira J
Endocrinology; 2004 Mar; 145(3):1269-75. PubMed ID: 14630719
[TBL] [Abstract][Full Text] [Related]
13. Autocrine and paracrine Müllerian inhibiting substance hormone signaling in reproduction.
Ingraham HA; Hirokawa Y; Roberts LM; Mellon SH; McGee E; Nachtigal MW; Visser JA
Recent Prog Horm Res; 2000; 55():53-67; discussion 67-8. PubMed ID: 11036933
[TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of the mouse P450 17 alpha-hydroxylase/C17-20-lyase gene (Cyp17): transcriptional regulation of the gene by cyclic adenosine 3',5'-monophosphate in MA-10 Leydig cells.
Youngblood GL; Payne AH
Mol Endocrinol; 1992 Jun; 6(6):927-34. PubMed ID: 1323057
[TBL] [Abstract][Full Text] [Related]
15. Müllerian-inhibiting substance type II receptor expression and function in purified rat Leydig cells.
Lee MM; Seah CC; Masiakos PT; Sottas CM; Preffer FI; Donahoe PK; Maclaughlin DT; Hardy MP
Endocrinology; 1999 Jun; 140(6):2819-27. PubMed ID: 10342873
[TBL] [Abstract][Full Text] [Related]
16. The orphan nuclear receptor steroidogenic factor-1 regulates the cyclic adenosine 3',5'-monophosphate-mediated transcriptional activation of rat cytochrome P450c17 (17 alpha-hydroxylase/c17-20 lyase).
Zhang P; Mellon SH
Mol Endocrinol; 1996 Feb; 10(2):147-58. PubMed ID: 8825555
[TBL] [Abstract][Full Text] [Related]
17. Müllerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Müllerian duct regression.
Zhan Y; Fujino A; MacLaughlin DT; Manganaro TF; Szotek PP; Arango NA; Teixeira J; Donahoe PK
Development; 2006 Jun; 133(12):2359-69. PubMed ID: 16687449
[TBL] [Abstract][Full Text] [Related]
18. Müllerian-inhibiting substance inhibits rat Leydig cell regeneration after ethylene dimethanesulphonate ablation.
Salva A; Hardy MP; Wu XF; Sottas CM; MacLaughlin DT; Donahoe PK; Lee MM
Biol Reprod; 2004 Mar; 70(3):600-7. PubMed ID: 14585814
[TBL] [Abstract][Full Text] [Related]
19. Endogenous expression of Müllerian inhibiting substance in early postnatal rat sertoli cells requires multiple steroidogenic factor-1 and GATA-4-binding sites.
Watanabe K; Clarke TR; Lane AH; Wang X; Donahoe PK
Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1624-9. PubMed ID: 10677509
[TBL] [Abstract][Full Text] [Related]
20. The in vivo roles of müllerian-inhibiting substance.
Behringer RR
Curr Top Dev Biol; 1994; 29():171-87. PubMed ID: 7828438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
